Your browser doesn't support javascript.
loading
Post hoc analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes: endo-metabolic features at baseline identify a subgroup of responders.
Sordi, Valeria; Monti, Paolo; Lampasona, Vito; Melzi, Raffaella; Pellegrini, Silvia; Keymeulen, Bart; Gillard, Pieter; Linn, Thomas; Bosi, Emanuele; Rose, Ludger; Pozzilli, Paolo; Giorgino, Francesco; Cossu, Efisio; Piemonti, Lorenzo.
Afiliación
  • Sordi V; Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Monti P; Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Lampasona V; Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Melzi R; Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Pellegrini S; Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Keymeulen B; The Belgian Diabetes Registry, Academic Hospital and Diabetes Research Centre, Vrije Universiteit Brussel, Brussels, Belgium.
  • Gillard P; Department of Endocrinology, University Hospitals Leuven-Katholieke Universiteit Leuven, Leuven, Belgium.
  • Linn T; Clinical Research Unit, Medical Clinic and Polyclinic III, Center of Internal Medicine, Justus Liebig University, Giessen, Germany.
  • Bosi E; Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Rose L; Università Vita-Salute San Raffaele, Milan, Italy.
  • Pozzilli P; Zentrum für Diabetes und Gefäßerkrankungen Münster, Munster, Germany.
  • Giorgino F; Department of Endocrinology and Metabolic Diseases, University Campus Bio-Medico, Rome, Italy.
  • Cossu E; Department of Emergency and Organ Transplantation, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy.
  • Piemonti L; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Front Endocrinol (Lausanne) ; 14: 1175640, 2023.
Article en En | MEDLINE | ID: mdl-37409229

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2023 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2023 Tipo del documento: Article País de afiliación: Italia